Management of Serrated Adenomas and Hyperplastic Polyps

ABSTRACT

The benign serrated architecture of the hyperplastic polyp has now been recognized in morphologically similar lesions with potential for transformation to colorectal carcinoma: the sessile serrated adenoma (SSA), traditional serrated adenoma (TSA), and mixed polyp. These represent a group of serrated polyps with potential to evolve into colorectal cancer through a different molecular pathway than the traditional adenoma–carcinoma sequence, called the serrated pathway. Genetic characteristics involve a defect in apoptosis caused by BRAF and K-ras mutations that create distinct histologic characteristics of atypia in serrated architectural distortion of the crypts. An evidence-based algorithm for the clinical management of this polyp has yet to be determined. Current recommendations suggest these lesions be managed similar to conventional adenomas. The histology of serrated polyps is reviewed, as well as the common characteristics, and implications for treatment and surveillance.

KEYWORDS

Hyperplastic polyp - sessile serrated adenoma - traditional serrated adenoma - mixed polyp - management

REFERENCES

• 1 Estrada R G, Spjut H J. Hyperplastic polyps of the large bowel.  Am J Surg Pathol. 1980;  4 127-133
• 2 Goldman H, Ming S, Hickock D F. Nature and significance of hyperplastic polyps of the human colon.  Arch Pathol. 1970;  89 349-354
• 3 Azimuddin K, Stasik J J, Khubchandani I T et al.. Hyperplastic polyps: “more than meets the eye”? Report of sixteen cases.  Dis Colon Rectum. 2000;  43 1309-1313
• 4 Warner A S, Glick M E, Fogt F. Multiple large hyperplastic polyps of the colon coincident with adenocarcinoma.  Am J Gastroenterol. 1994;  89 123-125
• 5 Jeevaratnam P, Cottier D S, Browett P J et al.. Familial giant hyperplastic polyposis predisposing to colorectal cancer: a new hereditary bowel cancer syndrome.  J Pathol. 1996;  179 20-25
• 6 Leggett B A, Devereaux B, Biden K et al.. Hyperplastic polyposis: association with colorectal cancer.  Am J Surg Pathol. 2001;  25 177-184
• 7 Torlakovic E, Snover D C. Serrated adenomatous polyposis in humans.  Gastroenterology. 1996;  110 748-755
• 8 Vogelstein B, Fearon E R, Hamilton S R et al.. Genetic alterations during colorectal-tumor development.  N Engl J Med. 1988;  319 525-532
• 9 Longacre T A, Fenoglio-Preiser C M. Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia.  Am J Surg Pathol. 1990;  14 524-537
• 10 Torlakovic E, Skovlund E, Snover D C, Torlakovic G, Nesland J M. Morphologic reappraisal of serrated colorectal polyps.  Am J Surg Pathol. 2003;  27 65-81
• 11 Goldstein N S, Bhanot P, Odish E, Hunter S. Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas.  Am J Clin Pathol. 2003;  119 778-796
• 12 Spring K J, Zhao Z Z, Karamatic R et al.. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy.  Gastroenterology. 2006;  131 1400-1407
• 13 Jass J R. Serrated route to colorectal cancer: back street or super highway?.  J Pathol. 2001;  193 283-285
• 14 Jass J R. Hyperplastic-like polyps as precursors of microsatellite-unstable colorectal cancer.  Am J Clin Pathol. 2003;  119 773-775
• 15 Jass J R, Whitehall V L, Young J, Leggett B A. Emerging concepts in colorectal neoplasia.  Gastroenterology. 2002;  123 862-876
• 16 Chan T L, Zhao W, Leung S Y, Yuen S T. BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas.  Cancer Res. 2003;  63 4878-4881
• 17 Koinuma K, Shitoh K, Miyakura Y et al.. Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomas.  Int J Cancer. 2004;  108 237-242
• 18 Iino H, Jass J R, Simms L A et al.. DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer?.  J Clin Pathol. 1999;  52 5-9
• 19 O'Brien M J, Yang S, Mack C et al.. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.  Am J Surg Pathol. 2006;  30 1491-1501
• 20 O'Brien M J. Hyperplastic and serrated polyps of the colorectum.  Gastroenterol Clin North Am. 2007;  36(4) 947-968 vii
• 21 Bensen S P, Cole B F, Mott L A et al.. Colorectal hyperplastic polyps and risk of recurrence of adenomas and hyperplastic polyps. Polyps Prevention Study.  Lancet. 1999;  354 1873-1874
• 22 Bond J H. Polyp guideline: diagnosis, treatment, and surveillance for patients with colorectal polyps. Practice Parameters Committee of the American College of Gastroenterology.  Am J Gastroenterol. 2000;  95 3053-3063
• 23 Kudo S, Hirota S, Nakajima T et al.. Colorectal tumours and pit pattern.  J Clin Pathol. 1994;  47 880-885
• 24 Harvey N T, Ruszkiewicz A. Serrated neoplasia of the colorectum.  World J Gastroenterol. 2007;  13 3792-3798
• 25 Jass J R, Baker K, Zlobec I et al.. Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a ‘fusion’ pathway to colorectal cancer.  Histopathology. 2006;  49 121-131
• 26 Snover D C. Serrated polyps of the large intestine.  Semin Diagn Pathol. 2005;  22 301-308
• 27 Snover D C, Jass J R, Fenoglio-Preiser C, Batts K P. Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept.  Am J Clin Pathol. 2005;  124 380-391
• 28 Sano Y, Yoshida S. Optical chromoendoscopy using NBI during screening colonoscopy: its usefulness and application. In: Cohen J Advanced Digestive Endoscopy: Comprehensive Atlas of High Resolution Endoscopy and Narrowband Imaging. Malden, MA; Blackwell Publishing 2007: 123-131
• 29 Farris A B, Misdraji J, Srivastava A et al.. Sessile serrated adenoma: challenging discrimination from other serrated colonic polyps.  Am J Surg Pathol. 2008;  32 30-35